Federal Register of Legislation - Australian Government

Skip to primary navigation Skip to primary content
Federal Register of Legislation Skip to Content
SearchOpen search

Primary content

Bookmark

this version | go to latest

National Health Act 1953 - Amendment determination under paragraph 98C(1)(b) - conditions (No. PB 131 of 2008)

Authoritative Version
  • - F2008L04645
  • No longer in force
PB 131 of 2008 Determinations/Health as made
This Determination amends the National Health Act 1953 - Determination under paragraph 98C(1)(b) - conditions (No. PB 119 of 2008) to enable the addition of listed drug 'Posaconazole' as an Oral suspension 40 mg per mL, 105 mL.
Administered by: Health
Registered 11 Dec 2008
Tabling HistoryDate
Tabled HR03-Feb-2009
Tabled Senate03-Feb-2009
Date of repeal 19 Mar 2014
Repealed by Health (Spent and Redundant Instruments) Repeal Regulation 2014

 

COMMONWEALTH OF AUSTRALIA

Instrument number PB 131 of 2008

Amendment determination under paragraph 98C(1)(b) of the National Health Act 1953

I, DIANA MACDONELL, Acting Assistant Secretary, Pharmaceutical Evaluation Branch, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this instrument under paragraph 98C(1)(b) of the National Health Act 1953.

 

Dated 3rd DECEMBER                                               2008

 

 

 

 

 

DIANA MACDONELL

Acting Assistant Secretary

Pharmaceutical Evaluation Branch

Department of Health and Ageing

Amendment determination — conditions

1              Commencement                                                        

                This instrument commences on 1 January 2009.

2              Amendment of PB 119 of 2008

                Schedule 1 amends PB 119 of 2008.

Schedule 1            Amendments

[1]     Schedule 4, after items dealing with Polyvinyl Alcohol

insert in the columns in the order indicated:

Posaconazole

Oral suspension 40 mg per ml, 105 mL